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Social anxiety disorder (SAD) is a debilitating condition, and it is estimated that 
approximately half of adults who stutter have SAD. Thus, there is a need for the assessment and 
treatment of SAD in this population. Cognitive-behavioral therapy (CBT) has shown promise in 
decreasing anxiety symptoms among adults who stutter and have SAD, but exposure, the key 
ingredient for successful CBT for SAD, has been understudied and underemphasized. The aims 
of this study were to develop an exposure therapy protocol specifically for people who stutter 
and have SAD and to evaluate its efficacy for reducing anxiety and stuttering severity. Utilizing 
a multiple baseline design, six participants were randomized to receive zero, two, or four 
sessions of progressive muscle relaxation therapy. This served to establish the staggered start and 
to account for the common factors of therapy. All participants received ten sessions of exposure 
therapy. Participants recorded daily social anxiety levels, and anxiety and stuttering severity 
were assessed at major assessment points. All participants demonstrated substantial reductions in 
social anxiety and substantial improvements in the affective, behavioral, and cognitive 
experiences of stuttering following exposure therapy. No reliable change was observed for 
stuttering frequency. Results suggest that exposure therapy may be useful for people who stutter 
and have SAD, but will not necessarily influence their speech fluency. These findings underscore 
the importance of the assessment and treatment of SAD among adults who stutter and suggest 
that the integration of care between psychologists and speech-language pathologists may prove 
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CHAPTER 1: INTRODUCTION 
1.1 Social Anxiety Disorder 
Social anxiety disorder (SAD), also known as social phobia, is an anxiety disorder 
characterized by fear of social judgment. Situations that individuals with SAD may fear, avoid, 
and/or endure with distress include social interactions, being observed, and performing in front 
of others. In particular, individuals with SAD fear that they will be negatively evaluated. With a 
lifetime prevalence of approximately 12%, SAD is one of the most prevalent lifetime mental 
disorders, following only major depressive disorder, alcohol abuse, and specific phobia (Kessler 
et al., 2005).  
SAD is a serious, debilitating condition. The impairment and the associated reduced 
quality of life are substantial (Stein & Kean, 2000). Individuals with SAD experience more 
scholastic difficulties, dysfunction in daily activities, and problems related to interpersonal 
relationships (Stein & Kean, 2000). Quality of life for individuals with SAD is influenced by 
reduced satisfaction with leisure and daily activities, family life, friends, and income (Stein & 
Kean, 2000). Additional negative outcomes associated with SAD include increased cannabis and 
alcohol dependence (Buckner et al., 2008) and additional psychiatric disorders, especially other 
anxiety disorders and depression (Schneier, Johnson, Hornig, Liebowitz, & Weissman, 1992). 
When SAD is comorbid with other psychiatric disorders, it is associated with increased financial 
dependence and an increased number of suicide attempts (Schneier et al., 1992).  
Due to the discomfort of social interactions, many individuals with SAD tend to engage 
in avoidant behavior, which may include overt or subtle avoidance. Simply avoiding social 
situations constitutes overt avoidance. Subtle avoidance may involve the individuals with SAD 
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focusing on themselves rather than the situation (Bögels & Mansell, 2004), mentally distancing 
themselves from the feared situation (Rodebaugh, Holaway, & Heimberg, 2004), or the use of 
safety behaviors (Wells et al., 1995). Safety behaviors in SAD are performed in an effort to 
reduce the likelihood of negative social evaluation. For example, researchers identified safety 
behaviors such as speaking quickly, taking deep breaths, rehearsing sentences, and avoiding eye 
contact in a participant with SAD who feared talking to a group of strangers (Wells et al., 1995). 
While the intention of engaging in safety behaviors is to avert fears, like other methods of 
avoidance, safety behaviors are problematic because they actually contribute to the maintenance 
and exacerbation of fear (Helbig‐Lang & Petermann, 2010; Wells et al., 1995). Engaging in 
safety behaviors prevents full exposure to the feared event. Safety behaviors may prevent 
individuals from fully habituating to their feared event and/or from disconfirming their beliefs 
that they will be negatively evaluated (Kim, 2005; Wells et al., 1995).  
1.2 Stuttering 
Stuttering is a communication disorder characterized by involuntary interruptions in the 
forward flow of speech (Bloodstein & Bernstein Ratner, 2008). Most researchers and speech-
language pathologists agree that stuttering consists of sound, syllable, or monosyllabic word 
repetitions; oral or silent sound prolongations; and broken words. The current edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric 
Association, APA, 2013) places stuttering, also called childhood-onset fluency disorder, 
alongside other communication disorders in the neurodevelopmental disorders category. The 
lifetime prevalence of stuttering is estimated to be approximately 4% - 5%, while at any given 
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point in time, about 1% of the population stutters (Bloodstein & Bernstein Ratner, 2008). In 
adulthood, males who stutter outnumber females who stutter four to one (Iverach, O'Brian, et al., 
2009).  
 Stuttering is a universal disorder which often presents prior to age three, but the age of 
onset ranges from two to seven years (APA, 2013; Yairi & Ambrose, 1992), which largely 
coincides with the speech and language developmental period. Onset can be gradual or rapid 
(APA, 2013; Yairi & Ambrose, 1992). Although the cause of stuttering remains elusive, 
neurological deficits are a likely component (Bloodstein & Bernstein Ratner, 2008; Smits-
Bandstra & Luc, 2007) and genetic factors are likely involved (Bloodstein & Bernstein Ratner, 
2008; Domingues et al., 2014; Frigerio‐Domingues & Drayna, 2017).  
While the majority of children who stutter naturally recover, stuttering develops into a 
lifelong problem for a small but significant proportion of adults (APA, 2013; Onslow, 2004). By 
disrupting speech production, stuttering impedes the ability to communicate effectively. 
Communication through speech is important to social and occupational functioning and overall 
quality of life (Iverach, O'Brian, et al., 2009). Thus, it is no surprise that stuttering is associated 
with numerous negative outcomes throughout the lifespan. Children as young as three who 
stutter are more likely to demonstrate impaired behavioral, emotional, and social development 
compared to typically-developing children (McAllister, 2016). Stuttering has the potential to 
elicit negative peer responses for children as young as three and four years old (Langevin, 
Packman, & Onslow, 2009). Preschool and kindergarten children who stutter report a more 
negative attitude about their speech than their nonstuttering peers (Vanryckeghem, Brutten, & 
Hernandez, 2005). Children who stutter are more likely to be rejected by their peers (Davis, 
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Howell, & Cooke, 2002); they are less likely to be popular (Davis et al., 2002); and they are 
often bullied (Blood & Blood, 2007). In adolescence, stuttering continues to be associated with 
greater risk for bullying, and it is also associated with lower self-perceived communicative 
competence (Blood & Blood, 2004). Adolescents who stutter who are at risk for bullying report 
lower self-esteem (Blood & Blood, 2004). Adults who stutter are at increased risk for developing 
social, psychological, and behavioral problems (Craig, 2003). 
In general, people who stutter are likely to experience negative stereotypes and listener 
reactions throughout their lives (Klompas & Ross, 2004; Snyder, 2001). These negative 
experiences may lead to low self-esteem, withdrawal, and feelings of guilt, shame, 
embarrassment, and frustration (Langevin & Prasad, 2012). It is understandable, then, that many 
people who stutter develop negative attitudes toward speaking (Andrews & Cutler, 1974; 
Erickson, 1969; Vanryckeghem & Brutten, 2011, 2012; Yaruss & Quesal, 2006). Similar to 
many individuals with SAD, many adults who stutter fear, struggle with, and/or avoid situations 
in which they have to speak, and they engage in overt and subtle avoidant behaviors as a means 
of coping (Lowe et al., 2017; Plexico, Manning, & Levitt, 2009; Vanryckeghem & Brutten, 
2011, 2012). Common subtle avoidant behaviors among people who stutter include substitution 
or avoidance of difficult words (Plexico et al., 2009). Indeed, the definition of stuttering, in 
addition to repetitions, prolongations, and blocking of sounds, often includes the substitution and 
avoidance of words (Bloodstein & Bernstein Ratner, 2008).   
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1.3 The Relationship between Social Anxiety and Stuttering 
The role of anxiety in stuttering has been debated over the years. Many theorists have 
speculated that anxiety might be causally linked to stuttering. Few people who stutter and few 
speech-language pathologists would deny the role of anxiety and emotional reactivity in 
stuttering. Recent research supports a neurological cause for stuttering, yet anxiety remains one 
of the most common concomitants of stuttering (Menzies, Onslow, & Packman, 1999; Smits-
Bandstra & Luc, 2007).  
The temporal relationship between anxiety and stuttering suggests that stuttering may 
engender anxiety. In a review and analysis, Alm (2014) found that preschool children who 
stuttered were neither shyer nor more socially anxious than peers who did not stutter; yet, 
speech-related social anxiety develops in many cases of stuttering before adulthood. It has been 
suggested that some people who stutter develop anxiety in adolescence (Smith et al., 2017), and 
that the development of social anxiety may be due to continued negative experiences with 
speaking (Menzies et al., 2008). Iverach, Lowe, et al. (2017) found that self-reported stuttering 
severity predicted higher anxiety among adolescents who stutter. In a meta-analysis including 
almost 1,300 adults, Craig and Tran (2014) found that the majority of adults who stutter have 
moderately elevated trait anxiety and substantially elevated social anxiety. Considering the 
inherent reliance on speaking in social interactions, elevated social anxiety among adults who 
stutter is unsurprising. There is a growing body of evidence supporting the significant prevalence 




The fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV-TR; APA, 2000) precluded a diagnosis of SAD among individuals whose anxiety was related 
to stuttering, presumably under the belief that elevated social anxiety was a reasonable reaction 
to stuttering. Nonetheless, many researchers advocated for increased assessment and treatment of 
anxiety among people who stutter (Iverach, O'Brian, et al., 2009; Menzies et al., 2008; Stein, 
Baird, & Walker, 1996), noting the significant and problematic prevalence of social anxiety 
symptoms. The most recent version of the DSM, the DSM-5, now allows for SAD to be 
diagnosed in people who stutter, as long as the social fear, avoidance, or distress is either 
unrelated or excessive to the stuttering (APA, 2013).  
It is clear that the role of anxiety, especially social anxiety, in stuttering is not fully 
understood, yet it is a serious problem for many adults who stutter. Hence, this matter merits 
further research.    
1.4 Clinical Implications 
Among children who stutter, an estimated 20% develop chronic stuttering (Craig, 2000). 
Among adults who stutter, an estimated 20% - 60% have significant social anxiety (Blumgart et 
al., 2010; Iverach, O'Brian, et al., 2009; Kraaimaat, Vanryckeghem, & Van Dam-Baggen, 2002; 
Menzies et al., 2008; Stein et al., 1996). In a study identifying the prevalence of anxiety 
disorders among children who stutter, Iverach et al. (2016) found that children who stutter had a 
six-fold increased odds for SAD compared to nonstuttering controls. In a study identifying the 
prevalence of anxiety disorders among treatment-seeking adults who stutter, Iverach, O'Brian, et 
al. (2009) found that adults who stutter had 16- to 34-fold increased odds of meeting criteria for 
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SAD compared to matched controls. The authors suggested that the comorbid presence of 
stuttering and significant anxiety might increase the likelihood that individuals who stutter will 
seek treatment for their stuttering. Noting the historical absence of SAD diagnoses, the authors 
elucidated the clinical implications of the exceptionally high prevalence of anxiety disorders 
among adults who stutter – the assessment and treatment of anxiety disorders, especially SAD, 
should be a critical priority among adults who stutter. It has been suggested that comprehensive 
treatment for stuttering should address anxiety specifically (Blumgart, Tran, & Craig, 2014; 
Craig, 1990; Iverach, Rapee, Wong, & Lowe, 2017), as targeted psychological assessment and 
intervention may improve overall stuttering treatment (Iverach, Jones, et al., 2009). Recently, 
researchers have advocated for the increased integration of care for adults who stutter between 
speech-language pathologists and clinical psychologists (Iverach, O'Brian, et al., 2009; Iverach 
& Rapee, 2014; Menzies et al., 2008).  
Current treatment for stuttering typically uses fluency shaping, stuttering modification, or 
an integration of both approaches. Fluency shaping aims to teach individuals who stutter to speak 
more fluently. The goal is to learn and apply techniques that facilitate more fluent speech. 
Fluency shaping often uses variations of prolonged speech, which focuses on speech rate 
modification and fluency shaping strategies, such as easy onset, soft contact, and delayed 
auditory feedback. Using these techniques, people who stutter are taught to slow their speech 
rate, systematically reshape their speech toward more normal sounding speech, and generalize 
their methods to use outside the clinic. While fluency shaping has proven to be effective at 
reducing stuttering severity (Andrews, Guitar, & Howie, 1980), it largely ignores any role of 
anxiety. Stuttering modification, on the other hand, typically utilizes a multidimensional 
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approach that incorporates behavioral, affective, and cognitive components. Treatment is often 
aimed at modifying neuro-motoric involvement in speech by employing techniques to decrease 
the tension associated with stuttering behaviors, to facilitate desensitization to stuttering, and to 
increase acceptance of stuttering (Blomgren, Roy, Callister, & Merrill, 2005). Common 
components of the stuttering modification approach include preparatory set, cancellation, and 
pull-out (Van Riper, 1982). As with fluency shaping, the ultimate goal is to generalize these 
methods to use outside the clinic. Notably, while stuttering modification addresses anxiety, it 
does not explicitly address the widespread social anxiety among people who stutter.  
Current treatment for SAD typically uses a form of cognitive-behavioral therapy (CBT), 
which has the greatest empirical support in the treatment of SAD (Rodebaugh et al., 2004). CBT 
can be considered a general term that incorporates a number of various techniques in varying 
combinations, such as exposure, applied relaxation, social skills trainings, and cognitive 
restructuring. However, exposure can be considered the essential component for successful 
treatment of SAD (Rodebaugh et al., 2004). In exposure therapy, the individual confronts his or 
her feared situations in a controlled manner. In SAD, the feared situations are social encounters 
in which the individual would be exposed to potential negative evaluation by others. The 
effectiveness of exposure in the treatment of SAD is supported in two separate meta-analytic 
reviews (Feske & Chambless, 1995; Gould, Buckminster, Pollack, & Otto, 1997). 
In an experimental clinical trial of a CBT package for adults who stutter, Menzies et al. 
(2008) randomized 30 adults who stutter (60% of whom were diagnosed with comorbid SAD) 
into two groups. One group received a speech restructuring treatment program, which consisted 
of procedures designed to control stuttered speech. Participants in this group learned to produce 
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prolonged speech at a slower rate, and they practiced the new speech pattern. The speech 
restructuring treatment program was deliberately stripped of any activities that related to 
cognitive and/or behavioral intervention that would overlap with CBT. The other group received 
CBT in addition to the speech restructuring treatment. The CBT package consisted of ten weekly 
sessions that incorporated cognitive restructuring, graded exposure, and behavioral experiments. 
In cognitive restructuring, the participants systematically identified and modified their irrational 
thoughts; in graded exposure, they gradually and progressively confronted their feared situations; 
and in the behavioral experiments, they compared predicted negative outcomes to actual 
outcomes of exposure exercises. The group that received CBT and speech restructuring treatment 
had superior and sustained measures of improved psychological functioning compared to the 
group that received speech restructuring treatment only. The groups did not significantly differ in 
stuttering severity following treatment. Some of the gains in psychological functioning were 
apparent after the experimental group completed CBT, before they began the speech 
restructuring treatment, which lends support for the effectiveness of isolated CBT for people who 
stutter. More recently, Helgadóttir, Menzies, Onslow, Packman, and O’Brian (2014) developed a 
standalone internet treatment based on the same CBT package and found similar results – 
significant post-treatment improvements in psychological functioning, but no significant changes 
in stuttering frequency. In 2016, they developed a fully automated version of the treatment and 
again found similar results – treatment completion was associated with significant improvements 
in self-reported psychological functioning. This study did not measure stuttering severity 
(Menzies, O’Brian, Lowe, Packman, & Onslow, 2016). While the CBT package used in these 
studies is consistent with other commonly used CBT packages, it borrows heavily from the 
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cognitive model of social anxiety – it neither emphasizes nor isolates the effectiveness of 
exposure, the key ingredient of CBT and gold standard treatment for SAD.  
Other researchers have reported positive outcomes from CBT with adults who stutter in 
both psychological functioning and speech fluency (Gupta, 2016; Gupta, Yashodharakumar, & 
Vasudha, 2016; Reddy, Sharma, & Shivashankar, 2010). However, they incorporated traditional 
speech-therapy techniques into their therapeutic programs. Thus, the isolated role of CBT is 
indeterminate. Similar to the other studies, they also emphasized a cognitive approach (e.g., 
relaxation techniques, cognitive restructuring), and thus underemphasized the role of exposure. 
Walkom (2016) developed and piloted a program of exposure therapy via virtual reality 
for people who stutter. Several adults who stutter engaged in two separate exposure tasks lasting 
5 minutes each that consisted of speaking in front of a virtual audience. Detailed outcome data 
were not reported, but the author concluded that the intervention showed promise in reducing 
anxiety and improving speech fluency among people who stutter and have social anxiety.   
No previous studies have rigorously investigated the isolated effectiveness of exposure 
therapy for people who stutter and have SAD. Therefore, the aim of this research study was to 
develop an exposure therapy protocol for this population and evaluate its efficacy in reducing 
anxiety and stuttering severity. Individuals who stutter are often anxious about speaking in front 
of others. More specifically, they are commonly fearful of pronouncing their name disfluently; 
they often substitute or avoid certain sounds and words that are associated with their stuttering 
behavior; and they vary in their level of anxiety surrounding extemporaneous speech versus 
reading aloud. Hence, the exposure task incorporated all of these situations. A multiple baseline 
across participants design was utilized to test the intervention in a cost- and time-effective 
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manner. As is common in multiple baseline design research, repeated measures were recorded 
during baseline and intervention phases. This study added a psychological placebo intervention 
prior to the proposed active intervention to account for the common factors of therapy, to provide 
additional support for the effectiveness of exposure therapy. It was hypothesized that social 
anxiety levels would remain stable during the baseline phase, reduce slightly during the 
psychological placebo intervention, decrease gradually and substantially during the exposure 
intervention, and remain low at the post-assessment. Social, state, and trait anxiety were assessed 
at major assessment points to further evaluate change. Social and state anxiety were expected to 
reduce after the exposure intervention. No change was expected for trait anxiety. To evaluate 
change stuttering severity, stuttering frequency and the affective, behavioral, and cognitive 
experiences of stuttering were also assessed at major assessment points, and they were expected 
to improve only after the exposure intervention. Finally, participants’ response to exposure 




CHAPTER 2: METHODS 
2.1 Participants 
Participants consisted of six individuals recruited from Central Florida. Inclusion criteria 
were: (a) at least 17 years of age; (b) English language proficiency; (c) met criteria for SAD, as 
defined by DSM-5 (confirmed via administration of Anxiety and Related Disorders Interview 
Schedule for DSM-5 [ADIS-5] - Adult Version); (d) if met criteria for another DSM-5 defined 
clinical disorder, SAD was determined to be primary (excluding childhood onset-fluency 
disorder [stuttering]); (e) onset of stuttering in early developmental period, not attributable to 
neurological insult or other medical condition; (f) stuttering frequency ≥ 3% of words spoken 
during reading or extemporaneous speech; and (g) if taking psychotropic medications, dose must 
be stabilized for at least two weeks. Exclusion criteria were: (a) elevated risk requiring a higher 
level of care, including current suicidal/homicidal intent, psychosis, or substance use disorder; 
(b) suspected intellectual developmental disorders, autism spectrum disorders, or comorbid 
communication disorders; (c) concurrent enrollment in psychotherapy or speech therapy; and (d) 
previous course of exposure-based therapy for social anxiety. 
Of note, towards the end of treatment, one of the participants (P6) revealed that they were 
concurrently enrolled in a program at their school based to their speech, but they were unsure if it 
was considered speech therapy. The program entailed meeting with an instructor at the school 
(unclear if this was a speech-language pathologist) and a peer with a different speech problem 
(diagnosis unknown) for approximately 0.5 hours per week. The participant reported that the 
sessions consisted of taking turns reading aloud with the peer. Due to the relatively low dose of 
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treatment and the absence of identifiable fluency shaping or stuttering modification techniques, 
this participant was included in the final analysis.  
Participant ages were 17, 19, 30, 31, 40 and 43; three were females and three were males; 
three were Caucasian, two were Hispanic, and one was Asian; two participants were married and 
four were single; highest level of education ranged from high school to university degrees; and 
employment included student, truck loader/unloader, financial services/risk management 
specialist, and computer engineer.  
2.2 Study Design 
This study utilized a randomized, nonconcurrent, multiple baseline across participants 
design (Barlow, Nock, & Hersen, 2009). All participants recorded at least seven days of baseline 
(BL) data, then they were randomized to receive zero, two, or four sessions of progressive 
muscle relaxation therapy (PMR). PMR has demonstrated minimal effects when used as an 
isolated intervention and has successfully served as a control condition in SAD treatment 
outcome studies (Rodebaugh et al., 2004). Thus, PMR served to establish the staggered start and 
to control for the common factors of therapy, which is the aim of a psychological placebo. 
During the subsequent exposure therapy (EXP) phase, all participants received ten sessions of 
individual EXP, two to three sessions per week. Of note, one of the participants (P3) elected to 
take an approximately one-month break from treatment between EXP sessions 6 and 7, citing 
unexpected work and family responsibilities. Due to the relative continuity of treatment gains, 
despite this gap, this participant was included in the final analysis. Throughout enrollment in the 
treatment program, participants recorded a daily rating of social anxiety. Additionally, all 
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participants completed a battery of assessments at major assessment points: BL, post-PMR, and 
post-EXP. 
The multiple baseline design allows for observation of symptom change over time. If 
symptoms change when and only when a new intervention is introduced, this allows for a causal 
inference about the effectiveness of the intervention. This study presents a unique adaptation of 
the multiple baseline design in that it utilizes a psychological placebo condition (PMR) to control 
for common factors of therapy before presenting the proposed active intervention (EXP). If the 
EXP leads to a reduction in symptoms above and beyond that of PMR, this will provide 
substantial support for the unique effectiveness of EXP. The use of a single case design is further 
justified due to the overall low base rate of the comorbid presentation of stuttering and SAD.  
2.3 Procedures 
Participants were recruited from the community via flyers posted at the University of 
Central Florida (UCF) Psychology Clinic and the UCF Communications Disorders Clinic and 
emails sent to members of an organization that supports people who stutter. Interested 
individuals who appeared to be eligible for the study were scheduled for part one of a two-part 
in-person assessment. In part one, a member of the research team provided an overview of the 
study, its purpose, and a brief description of the treatment and obtained informed consent. 
Participants were administered self-report questionnaires and speech samples were collected and 
recorded. Speech samples were independently transcribed and analyzed by two trained members 
of the research team, discrepancies were settled by consensus. The speech samples were 
reviewed by the master coder, a board certified fluency specialist, who confirmed the percentage 
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of words stuttered (%WS). Participants whose %WS was ≥ 3% during either reading or 
extemporaneous speech were scheduled for part two. In part two, participants were administered 
a clinical interview and additional self-report questionnaires. Participants who met diagnostic 
criteria for SAD and none of the exclusion criteria were eligible for continued participation in the 
study. Treatment was offered at no cost. 
The participants completed all self-report questionnaires with the assistance of a member 
of the research team. All assessment and treatment was conducted at the UCF Psychology Clinic 
by a clinical psychology doctoral student (the author), under the supervision of a licensed clinical 
psychologist. All procedures were approved by the University of Central Florida Institutional 
Review Board. 
Participant flow is presented in Figure 1. Since participants serve as their own controls, 
noncompleters do not have sufficient data to be included in the analyses. Thus, recruitment 
remained open until six participants completed the post-EXP assessment. Only one participant 
began the treatment and subsequently dropped-out. The participant accepted an out-of-state job 
offer. There were no discernable differences between completers and the one noncompleter in 









Throughout the BL, PMR, and EXP phases of the study, participants were provided with 
a Daily Behavioral Ratings (DBR) form, in which they monitored the frequency and severity of 
social- and speaking-related symptoms each day, such as overall social anxiety and avoided 
speaking situations. (See Appendix A.) The daily rating of overall social anxiety served as the 
main outcome for this study. Participants were asked to rate their social anxiety (0 – 10) each 
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day. Specifically, they were instructed: “Think over your whole day. How would you rate your 
overall anxiety due to social interactions or the possibility of social interactions?”  
The Social Phobia and Anxiety Inventory (SPAI; Beidel, Turner, Stanley, & Dancu, 
1989; Turner, Beidel, Dancu, & Stanley, 1989) and the State-Trait Anxiety Inventory (STAI) 
Form-Y (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983) were administered at major 
assessment points to further assess anxiety. The SPAI assesses the range and severity of social 
fears as well as the somatic, cognitive, and behavioral aspects of SAD. The SPAI has high test-
retest reliability (r = .86), good concurrent and external validity, and differentiates patients with 
SAD from normal controls or patients with other anxiety disorders. The STAI is a widely used 
measure for state and trait anxiety. It has demonstrated good psychometric properties 
(Spielberger et al., 1983).  
Presence of SAD and other clinical disorders were assessed via the Anxiety and Related 
Disorders Interview Schedule for DSM-5 (ADIS-5) - Adult Version (Brown & Barlow, 2013, 
2014), a semi-structured interview designed to diagnose anxiety and related disorders. It is the 
gold standard for the diagnosis of anxiety disorders and has well-established reliability and 
validity. All of the clinical interviews were audio and video recorded. Three recordings (25% of 
the total recordings) were randomly selected and viewed by an independent and blinded rater, 
also a clinical psychology doctoral student. Diagnostic agreement was 100%. 
2.4.1.2 Stuttering Severity 
Stuttering frequency was assessed at major assessment points via speech samples. 
Participants were audio and video recorded speaking in three contexts: reading, monologue, and 
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conversation. The speech samples were all collected in this order. For the reading sample, 
participants were provided with one of two 300-word scripts that were matched for reading level 
(Brutten, 1957). For the monologue sample, participants were asked to describe a series of 16 
photos, presented in a random order, until they had spoken approximately 300 words. For the 
conversation sample, participants were asked to engage in conversation with the assessor on a 
series of topics until they had spoken approximately 300 words. The speech samples were 
independently transcribed and coded by two research assistants trained to identify stuttering 
behaviors. Each word containing a stuttering behavior (sound, syllable, or monosyllabic word 
repetition; oral or silent sound prolongation; or broken word) was counted as a stuttered word. 
Percentage of words stuttered (%WS) was calculated in relation to the total number of words 
spoken. Discrepancies were agreed on by consensus. The master coder reviewed all BL samples, 
the first 150 words for each post-PMR sample, and all post-EXP samples. Research assistant 
consensus matched the master coder at an accuracy rate of 96.48%.  
The affective, behavioral, and cognitive experiences of stuttering were measured using 
the Behavioral Assessment Battery for Adults (BAB; Brutten, 1973, 1975; Vanryckeghem, 1999; 
Vanryckeghem & Brutten, in press). The BAB is a collection of self-report measures that assess 
affective, behavioral, and cognitive accounts of people who stutter. A modified version of the 
Fear Survey Schedule II (FSS-II; Geer, 1965), which is commonly included with the BAB, was 
also administered. The BAB is composed of the Speech Situation Checklist, the Behavior 
Checklist, and the Communication Attitude Test for Adults. These measures have been 
investigated internationally, have been shown to be reliable and valid, and can differentiate 
people who stutter from people who do not stutter. The Speech Situation Checklist (Bakker, 
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1995; Bakker & Brutten, 1982; Brutten, 1973, 1975; Brutten & Janssen, 1981) has two 
components. The Speech Situation Checklist - Emotional Reaction (SSC – ER) assesses negative 
emotional reaction, such as anxiety, concern, and worry, in speech situations (e.g., “talking on 
the telephone,” “giving directions,” “talking with teachers or supervisors”). The Speech Situation 
Checklist - Speech Disruption (SSC – SD) assesses speech disruption, described as getting stuck 
on, repeating, or prolonging sounds or words, in the same speech situations. In each component, 
the 38 speech situations are rated on a 5-point scale (1 = not at all to 5 = very much). The SSC 
has been shown to have high internal reliability (r = .95 and higher) and good content validity. 
The Behavior Checklist (BCL; Vanryckeghem, Brutten, Uddin, & Van Borsel, 2004) currently 
lists 60 behaviors (the original test had 95 items) that may be used as a means to escape or avoid 
a stutter (e.g., “touch or ruffle your hair,” “clear your throat,” “tap your foot/feet”). These 
behaviors are considered secondary to the stuttering. The rater is asked to indicate whether he or 
she engages in certain behaviors to help get sounds or words out, by indicating “yes” or “no” to 
each item. Items marked “yes” are rated on a 5-point scale relative to the frequency with which 
they are being used (1 = very infrequently to 5 = very frequently). The BCL has good internal 
reliability and validity, and it can reliably distinguish between people who stutter and people 
who do not stutter. The Communication Attitude Test for Adults (BigCAT; Vanryckeghem & 
Brutten, 2011, 2012; Vanryckeghem & Muir, 2016) is a 34-item true-false measure designed to 
assess speech-associated cognition (e.g., “There is something wrong with the way I speak,” 
“Speaking is no problem for me”). It has been shown to have good internal consistency for 
people who stutter (α = .84) and can reliably distinguish between people who stutter and people 
who do not stutter (Vanryckeghem & Brutten, 2011, 2012). Additionally, it has demonstrated 
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good test-retest reliability (r = .80) (Vanryckeghem & Muir, 2016). The FSS-II (Geer, 1965) is a 
51-item measure that lists objects and situations which may cause fear or discomfort (e.g., “sharp 
objects,” “worms,” “being criticized”). Internal consistency reliability has been found to be high. 
The FSS-II, which was originally on a 7-point scale, has been modified to be rated on a 5-point 
scale (from “not at all afraid” to “very much afraid”) to maintain consistency with SSC measures 
(Brutten, 1973). Participants completed the BAB and the FSS-II in this order: FSS-II, SSC - ER, 
BCL, BigCAT, SSC - SD. 
2.4.2 Secondary 
The Quality of Life Inventory (QOLI; Frisch, 1994) was administered to measure well-
being and life satisfaction. The QOLI is a brief psychological assessment that presents 16 life 
areas and asks respondents to rate how important (3-point rating scale) and how satisfied (6-point 
rating scale) they are with each area. It has been extensively evaluated and has demonstrated 
sound psychometric properties (Frisch, Cornell, Villanueva, & Retzlaff, 1992). The QOLI was 
administered at BL and post-EXP.  
The subjective and objective experience with EXP among the participants was an 
important exploratory area of interest in this research study. The credibility/expectancy 
questionnaire (Devilly & Borkovec, 2000) is a measure of treatment expectancy and rationale 
credibility specifically designed for use in outcome research. It has high internal consistency 
within each factor (credibility and expectancy) and good test-retest reliability. Participants 
completed this measure after two sessions of EXP. Between-sessions measures of anxiety and 
stuttering severity were assessed during the EXP phase. The Subjective Units of Distress (SUDs) 
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Scale is commonly used during exposure tasks in cognitive-behavioral therapy (CBT) for 
anxiety. Participants reported their SUDs on a 9-point scale (0 = no anxiety to 8 = extreme 
anxiety) at five-minute intervals. EXP sessions were transcribed and coded by research assistants 
trained to identify stuttering behaviors, so that %WS per five-minute interval could be 
calculated. Peak SUDs and peak %WS were evaluated for sessions 1, 5, and 10.  
Raters blind to session number viewed recordings of the first 20 minutes of each EXP 
session and rated the speaker on three components: level of anxiety (1 = none to 5 = very severe), 
level of stuttering (1 = none to 5 = very severe), and overall effectiveness of the presentation (1 = 
not at all to 5 = extremely) (see Appendix B). Indices of low levels of anxiety included frequent 
eye contact, appropriate volume of speech, occasional spontaneous speech, relaxed posture, open 
body position, and natural body movement. Indices of high levels of anxiety included minimal 
eye contact, low voice, lack of spontaneous speech, tense/frozen posture, hiding behind 
furniture/props, and excessive gross motor movements (hand wringing, leg shaking, fidgeting). 
Indices of low levels of stuttering included minimal identifiable stutters and minimal disruption 
to speech. Indices of high levels of stuttering included frequent stuttering and very disruptive to 
speech. Indices of low levels of overall effectiveness included looks awkward, unengaging, and 
appears uncomfortable. Indices of high levels of overall effectiveness included looks natural, 
engaging, and appears to enjoy presenting. Twelve sessions (20% of the sessions) were selected 
to determine inter-rater reliability. Overall, there was moderate agreement on the ratings (ICC = 
.725). Further examination of agreement by component demonstrated moderate agreement for 
ratings of anxiety (ICC = .567) and effectiveness (ICC = .731), and good agreement for ratings 




2.5.1 Progressive Muscle Relaxation Therapy (PMR) 
Participants were randomly assigned to receive zero, two, or four sessions of PMR. The 
PMR sessions were conducted individually and in-person, and they consisted of a guided 
progressive muscle relaxation exercise. The participants were instructed to relax, close their 
eyes, and focus on their breathing. Then, they were asked to tense various muscles in their body 
as they breathed in deeply, and then gently release the muscles as they breathed out fully. The 
exercise progressed through the major muscles in the body, beginning with the feet and ending 
with the face muscles. The therapist provided the participants with an opportunity to ask 
questions and address concerns about their anxiety and speech. Each session lasted 
approximately 50 minutes.  
2.5.2 Exposure Therapy (EXP) 
The EXP sessions were also conducted individually and in-person. All participants 
engaged in ten EXP sessions. At the beginning of each session, participants were provided with 
the script of the speech they would be presenting that day. Participants were provided with a 
different script each session. All participants received the same scripts in the same order. 
Participants were given ten minutes to review and prepare, and then they presented the speech in 
front of an audience of between three and six adults. Participants were asked to introduce 
themselves and their topic, present the speech, and deliver an impromptu response to a prompt 
related to the speech topic. This process (provide introduction, deliver speech, answer prompt) 
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was repeated as many times as was necessary until the session was ended. A unique prompt was 
provided each time.  
According to emotional processing theory, which aims to identify the mechanisms of 
action in EXP, an exposure task requires fear activation, within-session habituation, and 
between-session habituation in order to be successful in reducing fear and anxiety (Foa & Kozak, 
1986). To achieve fear activation, common fears among people who stutter were incorporated 
into the exposure task. First and foremost, individuals who stutter are commonly anxious about 
speaking in front of others, thus the exposure task consisted of speaking in front of a small 
audience. Individuals who stutter are commonly fearful of pronouncing their name disfluently, 
thus the exposure task required the participants to introduce themselves at the beginning of each 
speech. Individuals who stutter often substitute or avoid certain sounds and words that are 
associated with their stuttering behavior, thus each script incorporated all potential anxiety-
provoking sounds (i.e., each of the ten scripts contained at least one word that started with each 
letter of the English alphabet). Participants were instructed to state aloud all of the words from 
the script (although, they were free to elaborate). Individuals who stutter vary in their level of 
anxiety associated with reading aloud and extemporaneous speech production, thus the exposure 
task required participants to both read aloud from the provided script and deliver impromptu 
responses to prompts and questions. The audience members were encouraged to ask the 
participant questions throughout the exposure task. To ensure within-session habituation, the 
participants were asked to provide their SUDs at 5-minute intervals, and the exposure task was 
not ended until the participant reported that their SUDs was at least half that of their peak SUDs 
in that session, or overall distress was low (participant reported zeros or ones). (Between-session 
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habituation is not something that can be initially designed as part of the exposure, rather 
something that indicates progress over time.) 
Rationale credibility and treatment expectancy for EXP were examined, based on ratings 
on the credibility/expectancy questionnaire (Devilly & Borkovec, 2000). All participants found 
EXP to be highly logical (M = 8.17, SD = 0.75, range 7 to 9) and would be confident in 
recommending the treatment to a friend (M = 8.00, SD = 0.89, range 7 to 9). Participants were 
asked to rate how they thought and how they felt about EXP. All participants thought EXP would 
be successful in reducing their symptoms (M = 7.17, SD = 1.17, range 6 to 9). Four participants 
thought there would be 70% - 80% improvement and two participants thought there would be 
30% - 40% improvement in symptoms (M = 0.60, SD = 0.20, range 30% to 80%). All 
participants reported that they felt that EXP would reduce their symptoms (M = 6.50, SD = 1.05, 
range 5 to 8). Three participants felt there would be 70% improvement and three participants felt 
there would be 30% - 60% improvement in symptoms (M = 0.58, SD = 0.16, range 30% to 70%). 
Overall, the participants reported high credibility and expectancy for EXP. 
2.6 Data Analysis 
 Data analysis was conducted in a manner consistent with that of a multiple baseline 
design (Barlow et al., 2009). However, this study included a psychological placebo (PMR) to 
establish the staggered start, which is traditionally accomplished by manipulating the length of 
the baseline. Change due to common factors of therapy should be captured in the PMR phase, 
thus changes that are apparent only after the active intervention (EXP), can be more confidently 
attributed to the proposed active ingredients of EXP. Each participant recorded daily ratings of 
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social anxiety during each phase (BL, PMR, and EXP). The daily ratings of social anxiety were 
graphed over time, and the level and slope of the ratings for each phase were compared via visual 
inspection.  
Descriptive statistics were calculated for all of the measures administered at major 
assessment points: BL, post-PMR, and post-EXP. These data provide additional information 
about the magnitude of change attributable to PMR and EXP. Data from EXP sessions (peak 
SUDS; peak %WS; and the blinded observer ratings of anxiety, stuttering, and overall 
effectiveness) provide information about the subjective and objective changes between sessions 




CHAPTER 3: RESULTS 
3.1 Primary 
3.1.1 Anxiety 
Figure 3-1 displays social anxiety ratings during baseline (BL), psychological placebo 
(progressive muscle relaxation therapy; PMR), active intervention (exposure therapy; EXP), and 
the post-assessment (POST). BL data points represent the first seven days that the participants 
began recording daily social anxiety. Data points in the subsequent phases represent the average 
daily rating from one session to the next. The first PMR data point represents the participant’s 
social anxiety rating from that day, and the second PMR data point represents an average from 
the day after the first PMR session up to and including the second PMR session. Similarly, the 
first EXP data point represents the participant’s social anxiety rating from that day, and the 
second EXP data point represents an average from the day after the first EXP session up to and 
including the second EXP session. The POST data point represents an average from the day 
following the last EXP session up to and including the day of the post-assessment. Figure 3-1 
graphically displays the data for all six participants (P1 - P6). 
Visual inspection of the baseline data in Figure 3-1 indicates that social anxiety was 
stable or increasing for all participants except for P6. P6’s baseline ratings demonstrate a 
negative trend. During the PMR phase, social anxiety remained high for P3, initially reduced but 
demonstrated a positive trend for P4 and P5, and initially reduced and remained low for P6. 
During the EXP phase, social anxiety gradually and substantially decreased to below BL levels 
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for all participants except P6, whose social anxiety began reducing in BL and stayed low 





Daily social anxiety ratings for all participants across baseline (BL), progressive muscle 
relaxation therapy (PMR), and exposure therapy (EXP) phases, and at the post-assessment 
(POST). BL data points represent seven consecutive daily ratings. PMR1 and EXP1 represent the 
rating from the day of the session. All subsequent PMR and EXP data points represent an 
average of the ratings between sessions. The POST data point represents an average of the 
ratings following the final day of the intervention, up to and including the day of the post-
assessment.  
Figure 3-1: Daily Social Anxiety Ratings  
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The SPAI and STAI were administered at major assessment points (BL, post-PMR, and 
post-EXP). Table 3-1 presents the SPAI and STAI scores for each participant and the average of 
all participants at each assessment point. (Note that P1 and P2 do not have data at post-PMR 
because they were randomly assigned to receive zero sessions of PMR. They are not included in 
the post-PMR mean calculation.)  
SPAI scoring yields four qualitative categories: < 34 = Social Phobia Unlikely; 34 - 59 = 
Possible Mild Social Phobia; 60 - 79 = Possible Social Phobia; ≥ 80 = Probable Social Phobia. 
All SPAI scores were in the Probable Social Phobia range at BL (P1 = 117, P2 = 83, P3 = 137, 
P4 = 105, P5 = 108, P6 = 129) and remained there at post-PMR (P3 = 115, P4 = 109, P5 = 107, 
P6 = 111). At post-EXP, four participants reduced to the Possible Social Phobia range (P3 = 65, 
P4 = 61, P5 = 62, P6 = 70), one participant reduced to the Possible Mild Social Phobia range (P2 
= 35), and one participant reduced to the Social Phobia Unlikely range (P1 = 14). On average, 
participants were in the Probable Social Phobia range at BL (M = 113.17, SD = 19.17) and post-
PMR (M = 110.50, SD = 3.42) and reduced to the Possible Mild Social Phobia range at post-EXP 
(M = 51.17, SD = 21.92).  
The STAI produces two distinct scores: State Anxiety and Trait Anxiety. For State 
Anxiety, the mean score at BL was 45.67 (SD = 16.42, range 27 to 76); the mean score at post-
PMR was 46.00 (SD = 16.51, range 33 to 70); and the mean score at post-EXP was 27.83 (SD = 
5.27, range 22 to 37). For Trait Anxiety, the mean score at BL was 55.33 (SD = 15.28, range 37 
to 78); the mean score at post-PMR was 51.00 (SD = 13.63, range 41 to 71); and the mean score 
at post-EXP was 38.83 (SD = 7.03, range 30 to 51). In sum, SPAI and STAI scores were all 
elevated at BL and were not substantially different following PMR. However, SPAI and STAI 
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scores were all reduced following EXP. The SPAI scores, in particular, represented a reliable and 





Table 3-1: Anxiety at Major Assessment Points 
  BL Post-PMR Post-EXP 
P1    
SPAI 117 N/A 14 
STAI - State 40 N/A 28 
STAI - Trait 68 N/A 30 
P2    
SPAI 83 N/A 35 
STAI - State 45 N/A 22 
STAI - Trait 50 N/A 39 
P3    
SPAI 137 115 65 
STAI - State 76 70 30 
STAI - Trait 78 71 51 
P4    
SPAI 105 109 61 
STAI - State 39 43 25 
STAI - Trait 44 44 36 
P5    
SPAI 108 107 62 
STAI - State 47 33 25 
STAI - Trait 55 48 36 
P6    
SPAI 129 111 70 
STAI - State 27 38 37 
STAI - Trait 37 41 41 
  BL M (SD) Post-PMR M (SD) Post-EXP M (SD) 
Mean    
SPAI 113.17 (19.17) 110.50 (3.42) 51.17 (21.92) 
STAI - State 45.67 (16.42) 46.00 (16.51) 27.83 (5.27) 
STAI - Trait 55.33 (15.28) 51.00 (13.63) 38.83 (7.03) 
Note. P = Participant; SPAI = Social Phobia and Anxiety Inventory; STAI = State-Trait Anxiety 
Inventory; BL = baseline scores; Post-PMR = scores following PMR sessions; Post-EXP = 





Table 3-2 presents the clinical diagnoses for each participant at the BL and post-EXP 
assessments. At BL, all participants met criteria for SAD. One participant also met diagnostic 
criteria for a depressive disorder; specifically, the participant met criteria for persistent 
depressive disorder with persistent major depressive episode. At the post-EXP, no participants 
met criteria for any clinical disorders, except for one participant (P3) who retained the SAD 
diagnosis. Despite reduced fear and anxiety related to social situations, P3 reported experiencing 
continuing moderate distress and impairment related to social anxiety. 
 
Table 3-2: Clinical Diagnoses 
  BL Post-EXP 
P1 SAD, Depression None 
P2 SAD None 
P3 SAD SAD 
P4 SAD None 
P5 SAD None 
P6 SAD None 
Note. Diagnoses were based on ADIS-5 administration. P = Participant; BL = baseline scores; 
Post-EXP = scores following EXP sessions; SAD = social anxiety disorder; Depression = 
persistent depressive disorder with persistent major depressive episode. 
 
3.1.2 Stuttering Severity 
Table 3-3 presents the %WS by each participant in each of the three contexts - reading, 
monologue, and conversation - at each major assessment point. Table 3-3 includes a Total for 
each participant, which is an aggregate of the reading, monologue, and conversation samples. On 
average, adults who stutter exhibit stuttering behaviors on about 10% of words during oral 
reading (Bloodstein & Bernstein Ratner, 2008). Thus, the stuttering frequency of this sample was 
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higher than the general population of people who stutter. Table 3-3 includes averages across 
participants at the BL and post-EXP assessment points. The average at the post-PMR assessment 
point was excluded from this table as the two participants with the highest levels of stuttering 
frequency happened to be randomly assigned to receive zero PMR sessions. Thus, the average 
%WS at post-PMR would have appeared dramatically lower than at BL, artificially. 
P1’s %WS reduced from BL to post-EXP across all contexts. P2’s %WS increased from BL to 
post-EXP across all contexts. P3’s %WS for reading remained relatively stable from BL to post-
PMR, but increased slightly at post-EXP. The %WS for monologue and conversation decreased 
from BL to post-PMR, and then increased at post-EXP. P4’s %WS for reading decreased from 
BL to post-PMR, and decreased further at post-EXP. The %WS for monologue remained 
relatively stable from BL to post-PMR, but decreased at post-EXP. The %WS for conversation 
reduced from BL to post-PMR, but increased slightly at post-EXP. P5’s %WS for reading 
remained stable from BL to post-PMR, but increased dramatically at post-EXP. The %WS for 
monologue remained relatively stable from BL to post-PMR, and increased slightly at post-EXP. 
The %WS for conversation decreased from BL to post-PMR, and remained stable at post-EXP. 
P6’s %WS for reading and monologue decreased from BL to post-PMR, but returned to 
approximately BL levels at post-EXP. The %WS for conversation remained relatively stable 
from BL to post-PMR, but increased at post-EXP. Taken together, EXP appears to have led to a 
reduction in stuttering frequency for P1 and an increase in stuttering frequency for P2; the 
combined interventions appear to have led to a slight reduction in stuttering frequency for P4; 
and the interventions did not appear to have a significant effect on stuttering frequency for the 
remaining participants.   
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Table 3-3: Stuttering Frequency at Major Assessment Points 
  BL Post-PMR Post-EXP 
P1    
Reading 14.15% N/A 4.00% 
Monologue 25.68% N/A 19.47% 
Conversation 28.22% N/A 21.45% 
Total 23.04% N/A 15.53% 
P2    
Reading 35.14% N/A 45.34% 
Monologue 20.75% N/A 27.42% 
Conversation 16.76% N/A 20.67% 
Total 24.12% N/A 30.64% 
P3    
Reading 5.36% 5.67% 7.97% 
Monologue 4.45% 1.22% 7.01% 
Conversation 5.31% 3.18% 4.11% 
Total 5.03% 3.27% 6.19% 
P4    
Reading 6.35% 3.24% 0.96% 
Monologue 4.90% 5.56% 1.18% 
Conversation 5.95% 2.32% 4.08% 
Total 5.69% 3.78% 2.06% 
P5    
Reading 9.43% 8.36% 25.49% 
Monologue 13.79% 13.33% 17.43% 
Conversation 20.18% 12.71% 11.44% 
Total 14.53% 11.55% 17.29% 
P6    
Reading 13.46% 10.00% 15.65% 
Monologue 11.90% 8.61% 9.35% 
Conversation 7.36% 8.16% 12.91% 
Total 10.67% 8.90% 12.65% 
Mean    
Reading 13.98% N/A 16.57% 
Monologue 13.58% N/A 13.64% 
Conversation 13.96% N/A 12.44% 
Total 13.85% N/A 14.06% 
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Note. P = Participant; BL = baseline percentage; Post-PMR = percentage following PMR 
sessions; Post-EXP = percentage following EXP sessions.  
 
 
The FSS-II and the BAB were administered at major assessment points (BL, post-PMR, 
and post-EXP). Table 3-4 presents the average of all participants at each assessment point. (Note 
that post-PMR does not include data from P1 and P2).  
For the FSS-II, the mean score at BL was 134.50 (SD = 30.31, range 108 to 190); the 
mean score at post-PMR was 132.25 (SD = 45.76, range 95 to 199); and the mean score at post-
EXP was 111.50 (SD = 22.86, range 90 to 149). The total change is indicative of a reduction of 
0.60 SDs, according to established norms for people who stutter. 
For the SSC - ER, the mean score at BL was 148.67 (SD = 9.99, range 133 to 163); the 
mean score at post-PMR was 151.25 (SD = 20.90, range 132 to 176); and the mean score at post-
EXP was 86.50 (SD = 30.92, range 40 to 122). The total change is indicative of a reduction of 
2.17 SDs, according to established norms for people who stutter. 
For the SSC - SD the mean score at BL was 149.17 (SD = 15.20, range 135 to 169); the 
mean score at post-PMR was 148.00 (SD = 21.31, range 127 to 176); and the mean score at post-
EXP was 95.17 (SD = 34.72, range 43 to 138). The total change is indicative of a reduction of 
1.90 SDs, according to established norms for people who stutter. 
For the BCL, the mean score at BL was 35.17 (SD = 10.15, range 26 to 52); the mean 
score at post-PMR was 30.50 (SD = 10.08, range 22 to 45); and the mean score at post-EXP was 
22.50 (SD = 16.05, range 5 to 53). The total change is indicative of a reduction of 1.33 SDs, 
according to established norms for people who stutter. 
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For the BigCAT, the mean score at BL was 31.17 (SD = 2.64, range 27 to 34); the mean 
score at post-PMR was 31.75 (SD = 1.71, range 30 to 34); and the mean score at post-EXP was 
25.33 (SD = 7.99, range 13 to 32). The total change is indicative of a reduction of 1.11 SDs, 
according to established norms for people who stutter. 
Overall, the FSS-II and BAB scores remained relatively stable from BL to post-PMR, 






Table 3-4: The Affective, Behavioral, and Cognitive Experiences of Stuttering at Major 
Assessment Points 
  BL  Post-PMR  Post-EXP  
  M (SD) M (SD) M (SD) 
FSS-II 134.5 (30.31) 132.25 (45.76) 111.50 (22.86) 
BAB    
SSC – ER 148.67 (9.99) 151.25 (20.90) 86.50 (30.92) 
SSC – SD 149.17 (15.20) 148.00 (21.31) 95.17 (34.72) 
BCL 35.17 (10.15) 30.50 (10.08) 22.50 (16.05) 
BigCAT 31.17 (2.64) 31.75 (1.71) 25.33 (7.99) 
Note. FSS-II = Fear Survey Schedule II; BAB = Behavioral Assessment Battery; SSC – ER = 
Speech Situation Checklist – Emotional Reaction; SSC – SD = Speech Situation Checklist – 
Speech Disruption; BCL = Behavior Checklist; BigCAT = Communication Attitude Test for 
Adults; BL = baseline scores; Post-PMR = scores following PMR sessions; Post-EXP = scores 
following EXP sessions. 
 
3.2 Secondary 
Table 3-5 presents the QOLI scores for each participant at BL and post-EXP and includes 
an average score across all participants. The QOLI yields four qualitative categories based on T 
Score: < 37 = very low; 37 - 43 = low; 43 - 58 = average; 58 - 77 = high. At BL, three QOLI 
scores were in the very low range (P1 = 24, P3 = 28, P5 = 32) and three QOLI scores were in the 
average range (P2 = 53, P4 = 57, P6 = 46). At post-EXP, four participants remained in the same 
category, but two participants in the very low range at BL moved up to the average range. On 
average, participants were in the low range at BL (M = 40.00, SD = 13.84), and they were in the 
average range at post-EXP (M = 48.33, SD = 8.62). In sum, two participants demonstrated some 





Table 3-5: Quality of Life 
 BL Post-EXP 
  T-Score (Percentile) T-Score (Percentile) 
P1 24 (2%) 32 (5%) 
P2 53 (61%) 46 (34%) 
P3 28 (3%) 50 (49%) 
P4 57 (78%) 54 (66%) 
P5 32 (5%) 54 (66%) 
P6 46 (34%) 54 (66%) 
  BL Post-EXP 
  M (SD) M (SD) 
T-Score 40.00 (13.84) 48.33 (8.62) 
Percentile 30.50 (32.92) 47.67 (24.57) 
Note. BL = baseline scores; Post-EXP = scores following EXP sessions. 
 
 
A table presenting the between-EXP-session changes on self-report of anxiety and 
stuttering frequency among participants can be found in Appendix C. The table presents the 
participants’ peak SUDs and peak %WS at the beginning (Session 1), middle (Session 5), and 
end (Session 10) of EXP. The peak SUDs for each participant demonstrates a negative trend over 
time, which represents a reduction in peak anxiety between EXP sessions. The peak %WS for 
P1, P2, P4, and P5 demonstrates a negative trend over time, which represents a reduction in peak 
stuttering frequency between EXP sessions. The peak %WS for P3 increased from the beginning 
to the middle of EXP, and decreased slightly from the middle to the end. The peak %WS for P6 
remained stable from the beginning to the middle of EXP, and increased from the middle to the 
end. Overall, the peak SUDs consistently reduced over time, and the peak %WS also reduced 
over time, although less consistently.   
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A table presenting the between-EXP-session changes on objective observer ratings can be 
found in Appendix D. The table presents the blinded observer ratings of level of anxiety (1 = 
none to 5 = very severe), level of stuttering (1 = none to 5 = very severe), and overall 
effectiveness of the presentation (1 = not at all to 5 = extremely). The table includes the mean 
ratings across participants for each session. An examination of the mean scores reveals a steady 
negative trend in level of anxiety, a lesser but still apparent negative trend in level of stuttering, 
and a positive trend in overall effectiveness of the presentation. Upon examination of individual 
scores, P6 stands outs as an exception, as their anxiety, stuttering, and effectiveness ratings 





CHAPTER 4: DISCUSSION 
This study utilized a multiple baseline design to evaluate the efficacy of an exposure 
therapy protocol developed to reduce social anxiety among adults who stutter and have SAD. 
This study also sought to examine whether the hypothesized reduction in social anxiety was 
accompanied by a reduction in stuttering severity. The results indicated that, consistent with our 
hypotheses, there were no substantial decreases in social anxiety during the baseline or PMR 
phases, but five of the six participants demonstrated a gradual and substantial reduction in social 
anxiety throughout the EXP phase. One participant demonstrated a reduction in social anxiety 
during the baseline phase, and a small but apparent reduction in social anxiety during the PMR 
phase, which persisted throughout the EXP phase, suggesting a placebo effect (Wampold, 
Minami, Tierney, Baskin, & Bhati, 2005). These data suggest that the decrease in social anxiety 
is likely not due to repeated assessments, self-monitoring, time, chance, regression to the mean, 
or spontaneous recovery, but to EXP. The efficacy of EXP to reduce social anxiety was further 
supported in measures administered at major assessment points: following PMR, social anxiety 
was slightly, but not markedly improved compared to baseline, but social anxiety was 
substantially improved following EXP.  
Although less robust than social anxiety, state anxiety displayed a similar pattern: 
minimal reduction following PMR, but moderate reduction following EXP. These findings add 
to the literature that PMR alone has minimal effects in reducing social anxiety (see Rodebaugh et 
al., 2004), but contradict the literature that PMR is effective in reducing general anxiety (see 
Conrad & Roth, 2007). However, it is important to note two caveats. First, the role of PMR in 
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this study was simply that of a psychological placebo and a small number of sessions were 
provided to the participants. The very brief duration of the PMR intervention likely limited its 
effectiveness. Second, the population for this study included only participants with social anxiety 
disorder, and none met criteria for generalized anxiety disorder. Participants with generalized 
anxiety disorder may have demonstrated a greater reduction in general anxiety following PMR.   
Stuttering frequency did not demonstrate consistent change across participants. In at least 
three of the participants, the interventions did not appear to influence stuttering frequency in any 
consistent way. Perhaps the participants who demonstrated a reduction in anxiety, but no 
significant change in stuttering frequency, represent a portion of the population whose stutter is 
discrete from their anxiety.  
These findings are consistent with other research reporting improvements in 
psychological functioning, but no predictable change in speech fluency, following a CBT 
intervention (see Helgadóttir et al., 2014; Menzies et al., 2016; Menzies et al., 2008). The 
outcome of this investigation differs from several other investigations that reported speech 
fluency improvement along with improved psychological functioning (see Gupta, 2016; Gupta et 
al., 2016; Reddy et al., 2010); however, those studies incorporated an unknown amount of 
speech therapy into their therapeutic programs, which could have accounted for the 
improvements in speech fluency. In his proof-of-concept conference paper presentation, Walkom 
(2016) reported psychological and fluency gains using virtual reality EXP. However, outcomes 
were not rigorously assessed and detailed outcome data was not provided. In regards to speech 
fluency outcomes, he simply stated, “the participants showed signs of speaking more fluently.”  
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EXP appeared to most strongly influence the stuttering frequency of the two participants 
with the highest levels of stuttering frequency. Perhaps anxiety plays a more significant role in 
more severe cases of stuttering (Craig, Blumgart, & Tran, 2009; Iverach, Lowe, et al., 2017). 
However, EXP influenced the stuttering frequency for these two participants in opposite 
directions. The unique effects of EXP on stuttering frequency hint at the possibility of subgroups 
among people who stutter and have SAD. While anxiety may have no role in stuttering 
frequency for some people who stutter, it may play a larger role for people with higher levels of 
stuttering frequency. Future research should consider this possibility.  
Despite equivocal results regarding stuttering frequency, there were consistent 
improvements in the affective, behavioral, and cognitive experiences of stuttering. The affective, 
behavioral, and cognitive experiences of stuttering followed a similar pattern to anxiety – minor 
improvements following PMR and substantial improvements following EXP. Notably, 
participants reported a reduction in self-reported speech disruption. Thus, the participants 
reported improvements in their speech fluency in particular situations despite no consistent 
change in percentage of words stuttered. EXP may have its limits in reducing stuttering 
frequency among people who stutter and have SAD, but this study provides support for the 
effectiveness of EXP in improving their experience of stuttering.  
The self-focused attention theory, which postulates that excessive self-focused attention 
plays a role in a variety of psychopathologies, may provide an explanation for these findings (see 
Ingram, 1990 for a review). Clark and Wells (1995) and Rapee and Heimberg (1997) integrated 
the concept into a model for social anxiety specifically, theorizing that excessive self-focused 
attention before, during, and after social interactions generates and maintains social anxiety (for 
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reviews, see Bögels & Mansell, 2004; Norton & Abbott, 2016; Spurr & Stopa, 2002). 
Therapeutically, reductions in self-focused attention are associated with less anxiety and social 
fear and less self-criticism (Woody, Chambless, & Glass, 1997). It is possible that in the present 
study, as social anxiety reduced, so too did the focus on the self, including self-perceived speech 
disruption. Future research could examine self-focused attention as a possible mechanism of 
change. 
Although four of the six participants showed no significant change in quality of life, two 
of the three participants whose quality of life was very low at baseline made substantial gains by 
the post-EXP assessment. Although this may have been due to regression to the mean, both of 
these participants experienced substantial reductions in social anxiety. The EXP invention was 
brief (typically lasting four to five weeks), but improved functioning may translate to meaningful 
life changes that may boost overall quality of life, and participants’ quality of life may improve 
over time. Longer-term follow-up may be needed to determine the full impact on quality of life.  
The final aim of this study was to examine participants’ experience of EXP. Without 
exception, participants reported high treatment expectancy and rationale credibility for EXP. 
They provided these ratings after two sessions of EXP, arguably the most difficult sessions. 
Additionally, zero participants began EXP and subsequently dropped out. Concerns that this 
population cannot handle the intensive format of this therapy are not warranted. It is clear that 
EXP is acceptable and efficacious for this population. Finally, the between-EXP-session 
variables were examined. All participants demonstrated between-EXP-session anxiety 
habituation demonstrated by their self-report and scores by observers. These data are consistent 
with emotional processing theory as the mechanism by which EXP works. The peak %WS also 
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reduced between sessions, although less consistently. It is unclear whether this trend is an 
accurate reflection of reduced stuttering frequency over time or whether it is due to sampling 
error. Although the hypothesis was that as anxiety reduced, so too would stuttering frequency, 
this was not the case in the speech samples collected at major assessment points. Future research 
should include participants with more variability in stuttering severity and a larger sample size, 
and those data should be analyzed using inferential statistical procedures to further examine this 
issue.  
Interestingly, despite the lack of substantial change in stuttering frequency, the objective 
ratings of the blinded raters support a more consistent negative trend. Thus, even if the 
participants had no actual change in percentage of words stuttered, there was something about 
their presentations that led the raters to observe less disruption in their speech over time. It is a 
limitation of this study that stuttering frequency was coded dichotomously. It is possible that 
there was a change in the stuttering over time that was not captured in the dichotomous 
categorization of words as either stuttered or not stuttered. For example, “st-st-st-st-st-st-stop” 
and “st-stop” would both be considered a stuttered word, whereas the speech is clearly more 
disrupted in the former. Unfortunately, that was beyond the scope of this study, but would be 
worthy of future investigation.  
The blinded raters also rated overall effectiveness of the presentations. These ratings 
demonstrated a positive trend, meaning that the raters perceived the participants as more natural, 
more engaging, and more comfortable during their speeches over time. A common concern 
among the participants entering the study was distress and avoidance of public speaking at 
school and work, which they saw as impeding their potential to succeed in these areas. No 
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coaching or training about public speaking was provided during the intervention, yet the 
participants made gains in this area. This finding represents a clinically significant positive 
outcome.  
Overall, this study supports the use of intensive EXP for people who stutter and have 
SAD. Research on the use of CBT with this population is growing, but still limited. The mere 
mention of EXP is scant. For example, a recent review of therapies for stuttering included few 
references to CBT, and zero references to behavioral or exposure-based therapies (Humeniuk & 
Tarkowski, 2016). Nonetheless, people who stutter value treatment that targets psychological 
concerns, emphasizing that emotions and attitudes should be addressed in therapy for stuttering, 
regardless of the aim to improve speech fluency (Humeniuk & Tarkowski, 2016; Lindsay & 
Langevin, 2017). The results of the present study demonstrate the considerable gains that can 
occur in relatively few sessions of EXP. As researchers continue to refine treatments for people 
who stutter, the potential of EXP merits further use.  
An area of research that would be worthwhile to explore is the use of virtual reality. 
Virtual reality has demonstrated effectiveness in the treatment of SAD (Anderson et al., 2013; 
Anderson, Rothbaum, & Hodges, 2003; Klinger et al., 2005). The EXP sessions in the present 
study required several people to be available to play the role of the audience, which may not be 
as feasible in community settings. Walkom (2016) reported that speaking to virtual audiences 
showed promise in reducing anxiety and stuttering severity among people who stutter. Future 
research should investigate this promising mode of exposure-based intervention with increased 
rigor. That said, any version of CBT for people who stutter should be developed in conjunction 
with speech-language pathologists, as they are the traditional service providers for people who 
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stutter and can offer knowledge and insight into the unique situations of people who stutter. 
Similarly, it would be beneficial to obtain feedback from actual people who stutter throughout 
the development process.   
This study has several strengths. The multiple baseline design controlled for threats to 
internal validity. The inclusion of a psychological placebo controlled for change due to the 
common factors of therapy, which increased support for the unique effectiveness of EXP. The 
EXP protocol was developed specifically for a population that is comorbid for stuttering and 
SAD. Inclusion was limited to people who met clinical criteria for stuttering and other 
communication disorders were excluded, so this increases confidence that the effects found in 
this study will generalize to the population of people who stutter.  Further, the effect was 
replicated across diverse individuals, which also increases generalizability. There was a 
substantial decrease in anxiety levels after a relatively brief intervention. Outcome measures 
included self-report, clinician-ratings, and objective observer ratings. None of the participants 
dropped-out of the study after starting EXP.  
This study has limitations. A single therapist administered all of the treatment and most 
of the assessment; therefore, it is not possible to rule out the influence of therapist-specific 
effects, demand characteristics, and observer effects. Future research should evaluate the 
intervention administered by diverse therapists and incorporate a larger sample. While limiting 
inclusion to people who met clinical criteria for stuttering (and no other communication 
disorders) aids in the ability to generalize the finding to the population of people who stutter, this 
limits the ability to generalize the findings to people with other communication disorders. An 
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important future direction would be to evaluate the effectiveness of EXP for people with diverse 
communication disorders.  
In summary, the findings from this study provide preliminary evidence of the 
effectiveness of exposure therapy in reducing anxiety and improving the affective, behavioral, 
and cognitive experiences of stuttering among people who stutter and have SAD. This finding is 
in line with other research in this area that supports the effectiveness of CBT with this 
population. The brief nature of the intervention makes it well suited as a stand-alone 
intervention, or as an adjunct to other treatments, such as speech therapy. Speech-language 
pathologists and clinical psychologists should work together to develop, evaluate, and 





















APPENDIX C: PEAK SUDS AND PEAK %WS AT THE BEGINNING, 
MIDDLE, AND END OF EXPOSURE THERAPY 
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Peak SUDs and Peak %WS at the Beginning, Middle, and End of Exposure Therapy 
  Session 1  Session 5  Session 10 
P1    
Peak SUDS 6 2 0 
Peak %WS 23.91% 17.32% 16.27% 
P2    
Peak SUDS 6 5 4 
Peak %WS 19.57% 17.95% 12.50% 
P3    
Peak SUDS 6 3 1 
Peak %WS 3.21% 6.50% 4.16% 
P4    
Peak SUDS 5 3 2 
Peak %WS 5.35% 3.13% 3.59% 
P5    
Peak SUDS 8 4 1 
Peak %WS 30.77% 19.16% 20.52% 
P6    
Peak SUDS 5 1 1 
Peak %WS 9.33% 9.11% 12.40% 
Mean    
Peak SUDS 6 3 1.5 
Peak %WS 15.36% 12.20% 11.57% 




APPENDIX D: BLINDED OBSERVER RATINGS OF PARTICIPANTS’ 
ANXIETY, STUTTERING, AND THE OVERALL EFFECTIVENESS 




Blinded Observer Ratings of Participants’ Anxiety, Stuttering, and the Overall Effectiveness of 
Their Presentation  
  S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 
P1           
Anxiety 4 2 4 3 2 2 3 3 2 2 
Stuttering 5 4 3 4 3 3 3 2 3 2 
Effectiveness 3 2 3 3 3 4 2 2 2 3 
P2           
Anxiety 3 5 4 2 2 3 4 2 1 2 
Stuttering 3 3 4 3 4 3 4 3 2 3 
Effectiveness 3 2 2 4 3 3 2 3 4 4 
P3           
Anxiety 4 4 3 3 3 3 2 2 2 2 
Stuttering 3 3 2 3 3 2 2 2 3 2 
Effectiveness 2 2 3 2 2 2 3 4 3 3 
P4           
Anxiety 3 3 3 2 1 1 2 2 1 1 
Stuttering 3 4 2 1 1 2 2 2 2 1 
Effectiveness 2 3 3 4 4 4 4 4 4 5 
P5           
Anxiety 5 4 4 3 3 3 3 3 2 2 
Stuttering 5 3 4 4 4 3 3 4 3 3 
Effectiveness 2 2 2 2 3 3 3 3 3 4 
P6           
Anxiety 2 2 3 2 3 2 2 2 2 2 
Stuttering 2 2 2 2 4 2 3 2 3 2 
Effectiveness 4 3 2 3 2 4 3 3 3 3 
Mean           
Anxiety 3.50 3.33 3.50 2.50 2.33 2.33 2.67 2.33 1.67 1.83 
Stuttering 3.50 3.17 2.83 2.83 3.17 2.50 2.83 2.50 2.67 2.17 
Effectiveness 2.67 2.33 2.50 3.00 2.83 3.33 2.83 3.17 3.17 3.67 
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